Funding supports biomedical research
ANSTO part of consortium funded by Federal Government to develop new radioimmunological drugs.
Showing 941 - 960 of 2193 results
ANSTO part of consortium funded by Federal Government to develop new radioimmunological drugs.
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
Through the development and application of a robust safety management system, ANSTO strives to ensure that risks are as low as possible.
Research indicates that the portable x-ray fluorescence (XRF) is an appropriate analytical technique for determining seafood provenance at external sites.
Research on the mechanism of cell death has insights to bring progress on neurodegenerative diseases and plant biosecurity.
A team of researchers including the University of Rochester, CSIRO and ANSTO has found methane emissions from human fossil sources have been greatly underestimated.
$80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
ANSTO researchers are undertaking the fabrication and characterising advanced fuels and investigating the key properties of nuclear waste and its long-term interaction with containment materials to improve safety for short and long-term storage.
The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.
Applications are now being accepted for the Industry foundations Scholarship.
Multi-faceted approach to dating Australian Indigenous rock art from Kimberley region
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
ANSTO has made two public submissions to parliamentary inquiries with another to be submitted in February 2020 on matters relating to nuclear technologies, their peaceful applications, and the nuclear fuel cycle.